Press Releases

Clinical Chemistry Analyzers Market Value Projection to Expand by to 2022-2030 Analysis, Global Industry Size

Share This Article

Technologically Advanced Automated Clinical Chemistry Analyzers Gaining Popularity

The use of clinical chemistry analyzers has increased at a rapid pace over the past few decades, owing to significant advancements in technology and rising requirements of the healthcare industry. Clinical chemistry primarily focuses on the analysis of internal fluids within the body and offers accurate diagnostic insights. Conventional manual laboratory tests have laid a strong foundation for modern-day clinical chemistry. However, testing methods have evolved with advancements in technology and at present, several tests can be performed in automated laboratories using advanced instruments such as chemical analyzers.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111748

Significant developments in the design of modern-day clinical chemistry analyzers are expected to define the path of the clinical chemistry analyzers market, which is poised expected to reach a value of ~US$ 16.3 Bn by 2027. Groundbreaking technological advancements, improved production techniques, and entry of cutting-edge software are some of the factors that are projected to accelerate the growth of the clinical chemistry analyzers market during the forecast period (2019-2027). Hospitals, point of care diagnostic centers, research laboratories are the most prominent end users in the clinical chemistry analyzers market.

Automation in Clinical Chemistry – A Growing Trend

Computer technology has played a pivotal role in transforming the clinical chemistry segment, which, at present, is adopting informatics and automation. Automation in clinical chemistry has improved throughput to enable significantly higher testing volumes and efficiency, and minimizing human error. Moreover, automated clinical chemistry analyzers have proven their efficacy in minimizing cross-contamination and offer a high degree of safety from biohazard. The demand for automated chemistry analyzers has thus witnessed substantial growth in recent years and the trend is anticipated to continue during the forecast period. Fully automatic clinical chemistry analyzers are projected to account for ~64% share of the clinical chemistry analyzers market. This technology segment is expected to reach a value of ~US$ 10.4 Bn by 2027. The adoption of automated chemistry analyzers is expected to grow, as stakeholders in the clinical chemistry analyzers market value chain are leveraging favorable reimbursement policies and technologies to develop flexible instruments that offer superior performance than previous product types.

Future of Clinical Chemistry Analyzers Market Hinges on R&D Activities

The clinical chemistry analyzers market has continually witnessed innovations predominantly driven by the evolution of technology. Ongoing R&D activities, coupled with integration of advanced software technologies in clinical laboratories are expected to shape the future of clinical chemistry analyzers. Furthermore, stakeholders are likely to develop new products that are in-sync with the requirements of laboratories. Participants operating in the clinical chemistry analyzers market are engaged in the development of customized analyzers for small-scale laboratories. Additionally, manufacturers in the clinical chemistry analyzers market are increasingly developing downsized clinical chemistry analyzers that open the floodgates for improved testing capabilities. The next generation of clinical chemistry analyzers will further improve the workflow efficiencies in hospitals, point-of-care diagnostic centers, and research laboratories. Significant efforts are in store to integrate molecular diagnostics instruments and mass spectrometry with clinical chemistry systems.

Clinical Chemistry Analyzers Market Players Engage in Product Development

As the clinical chemistry analyzers market enters the automation era, manufacturers in the market are expected to focus on expanding their product portfolio by developing cutting-edge products according to current lab requirements. For instance, Trivitron Healthcare, an Indian health-tech company, launched a fully automated chemistry analyzer – ‘Nanolab 200’ in July 2019. The newly launched product is an automated benchtop chemistry analyzer that has a throughput of around 200 tests per hour. Integrated with cutting-edge liquid level detection technology, the newly launched product is expected to improve efficiency levels across clinical laboratories.

Companies are also focusing on opportunities in mid-sized laboratories wherein the integration of automated systems is a major challenge. Several manufacturers are launching compact analyzers with improved turn-around-time (TAT). For instance, in August 2019, the ERBA Group launched a new range of clinical chemistry analyzers, including XL 200 and XL 640 that are easier to operate and integrate with the advanced software version.

Analysts’  Viewpoint

The clinical chemistry analyzers market is expected to grow at a CAGR of ~4% during the forecast period. Automation will continue to fuel major developments in the clinical chemistry analyzer market. Companies operating in the current landscape should identify evolving requirements of clinical laboratories and develop new products with improved throughput. Research and development activities will continue to play a key role in the development of future generations of clinical laboratory instruments. Due to significant technological developments in North America and Europe, these regions will continue to remain the most prominent markets for clinical chemistry analyzers during the forecast period.

View full report@ https://qyresearchmedical.com/report/clinical-chemistry-analyzers-market-product-panels-reagents-and-analyzers-technology-semi-automatic-and-fully-automatic-modality-centralized-and-decentralized-and-end-user-hospitals-diagnostic-centers-ac-019-2030/111748

Clinical Chemistry Analyzers Market: Overview

According to Transparency Market Research’s latest market report on the clinical chemistry analyzers market for the historical period of 2017–2018 and forecast period of 2019–2027, rise in prevalence of chronic diseases and adoption of point-of-care testing in diagnosis of various diseases are anticipated to drive the global clinical chemistry analyzers market

According to the report, the global clinical chemistry analyzers market was valued at ~US$ 11.3 Bn in 2018. The clinical chemistry analyzers market is projected to expand at a CAGR of ~4% from 2019 to 2027.

Increase in Demand for Portable Devices and Point-of-Care Testing to Accelerate Clinical Chemistry Analyzers Market Growth

Point-of care testing is driving the clinical chemistry analyzers market. The point-of-care testing is driven by technological advancements as well as patient reference. Manufacturers are making continuous progress in terms of research & development to create products with newer, advanced technologies. For instance, sensor technologies enable rapid analysis of blood samples for several critical care assays, including chemistries, electrolytes, blood gases, and hematology.

Technological innovations, such as next generation microfluidic devices are capable of efficient separation of CTCs from whole blood. These devices require low consumption of reagents and samples, and provide fast turnaround time for analysis. Technological advancements in point-of-care testing devices have contributed to the growth of clinical chemistry analyzers.

Increase in burden of chronic diseases across the globe, especially in developed countries, has resulted in the adoption of portable clinical chemistry analyzers. Hence, rise in demand for portable or benchtop clinical chemistry analyzers is expected to result in reduced health care costs and lead to enhanced rate of diagnosis and treatment, which would subsequently propel the global clinical chemistry analyzers market.

Large Target Patient Pool

Rise in incidence of lifestyle diseases such as cardiac diseases and diabetes, increase in incidence of infectious diseases in developing countries, growth in usage of home-based point-of-care devices, and technological advancements with regard to development of advanced, fast, and easy-to-use devices are fueling the demand for clinical chemistry analyzers

Consistent rise in geriatric population leads to increased risk of acquiring several chronic disorders, thereby creating a need and demand for effective diagnostic and therapeutic methodologies. This, in turn, influences the growth of the clinical chemistry analyzers market.

In May 2019, Beckman Coulter introduced DxA 5000, the total laboratory automation solution, which has received European CE Mark and China Food and Drug Administration approval. The DxA 5000 utilizes intelligent routing to bring automated patient-centric workflow to the laboratory. By comprehending the tests requested and availability of sample volume, the DxA 5000 constantly calculates the most prompt route for every patient sample.

Introduction of new products and advanced technologies are likely to fuel the growth of the global clinical chemistry analyzers market

High Cost of Automated Instruments to Hamper Clinical Chemistry Analyzers Market

Advancements in technology in clinical chemistry analyzers carry a heavy price tag. The cost of analyzers is increasing with rise in automation and integration of clinical analyzers. Laboratories cannot afford high cost instruments. Therefore, instruments, which are cost-effective and easy-to-use, are needed.

High instrument cost can increase testing expenditure, which can restrain the global clinical chemistry analyzers market during the forecast period

Clinical Chemistry Analyzers Market: Competition Landscape

This report profiles major players in the global clinical chemistry analyzers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111748/2900

The clinical chemistry analyzers market is moderately fragmented, with the presence of a few large-scale players present in international market and numerous small-scale players in regional markets. Top four to five players hold majority share of the global clinical chemistry analyzers market.

Prominent players operating in the global clinical chemistry analyzers market include

  • Ortho Clinical Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Randox Laboratories Ltd
  • Siemens Healthineers
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Mindray Medical International Limited

Key Questions Answered in Clinical Chemistry Analyzers Market Report

  • What is the scope of growth of companies in the clinical chemistry analyzers market?
  • What will be the Y-o-Y growth of the clinical chemistry analyzers market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global clinical chemistry analyzers market?
  • Will North America continue to remain the most profitable regional market for clinical chemistry analyzers providers?
  • Which factors will impede the growth of the global clinical chemistry analyzers market during the forecast period?
  • Which are the leading companies in the global clinical chemistry analyzers market?

Clinical Chemistry Analyzers Market – Segmentation

Product

  • Panels & Reagents
  • Analyzers

Technology

  • Semi-automatic
  • Fully Automatic

Modality

  • Centralized
  • Decentralized

End User

  • Hospitals
  • Diagnostic Centers
  • Academic Research Institutes
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1.  Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Clinical Chemistry Analyzers Market

4. Market Overview

4.1. Introduction

4.1.1. Definition

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.4. Global Clinical Chemistry Analyzers Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Technological Advancements

5.2. Regulatory Scenario

6. Global Clinical Chemistry Analyzers Market Analysis and Forecast, by Product

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Clinical Chemistry Analyzers Market  Revenue (US$ Mn) Forecast, by Product, 2017–2027

6.2.1. Panels & Reagents

6.2.2. Analyzers

6.3. Global Clinical Chemistry Analyzers Market Attractiveness, by Product

7. Global Clinical Chemistry Analyzers Market Analysis and Forecast, by Technology

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Clinical Chemistry Analyzers Market Revenue (US$ Mn) Forecast, by Technology, 2017–2027

7.2.1. Semi-automatic

7.2.2. Fully Automatic

7.3. Global Clinical Chemistry Analyzers Market Attractiveness, by Technology

8. Global Clinical Chemistry Analyzers Market Analysis and Forecast, by Modality

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Global Clinical Chemistry Analyzers Market Revenue (US$ Mn) Forecast, by Modality, 2017–2027

8.2.1. Centralized

8.2.2. Decentralized

8.3. Global Clinical Chemistry Analyzers Market Attractiveness, by Modality

9. Global Clinical Chemistry Analyzers Market Analysis and Forecast, by End User

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111748/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button